Skip to main content
. 2020 Mar 31;48(9):4960–4975. doi: 10.1093/nar/gkaa199

Figure 6.

Figure 6.

EXO1 expression as a marker for cancer prognosis. (A) FPKM expression values across 16 cancer subtypes. (B–E) Kaplan–Meier survival curve of cancers sorted by high (orange) and low (blue) expression of EXO1. Melanoma: low expression, n = 74; high expression, n = 28; P = 2e−04. Endometrial cancer: low expression, n = 136; high expression, n = 405; P = 0.0041. Liver cancer: low expression, n = 289; high expression, n = 76; P < 0.0001. Renal cancer: low expression, n = 694; high expression, n = 183; P < 0.0001.